The glyphosate review process moved into a more active phase on August 25, 2026, when the U.S. Environmental Protection Agency released an open literature search document for public feedback to inform an updated human health risk assessment of glyphosate. The document covers studies published since EPA’s last open literature search in 2017, and the agency has said the updated human health risk assessment is scheduled for completion in late 2026. EPA described the release in its glyphosate literature notice.
For crop producers, pesticide applicators, agronomists, and input suppliers, the review is not just a regulatory event. Glyphosate remains widely connected to weed control programs, conservation tillage systems, crop rotation planning, and herbicide-resistance management. Any future label changes could affect application timing, drift controls, use-rate decisions, aquatic hazard language, or resistance-management requirements. At the same time, EPA has not issued a final updated risk assessment as of October 14, 2026, so changes should not be treated as settled before the agency completes its work.
Why The Glyphosate Review Process Matters
What The Glyphosate Review Process Covers
The glyphosate review process sits within the Federal Insecticide, Fungicide, and Rodenticide Act framework. Under that law, EPA must review each registered pesticide at least every 15 years to determine whether it continues to meet federal safety standards. Glyphosate’s registration review began in 2009, which helps explain why the current assessment has become a major issue for crop protection policy.
The present review includes several distinct questions. EPA is preparing an updated human health risk assessment. The agency is also working through Endangered Species Act obligations after prior litigation affected earlier portions of the registration review. Separate scientific and policy issues include occupational exposure, formulation toxicity, surfactants, biomonitoring, cancer risk, ecological effects, spray drift, aquatic hazards, and resistance-related label language.
That breadth matters because growers often use glyphosate as one part of a broader weed-control system. A label revision focused on drift can affect nozzle selection, wind-speed restrictions, buffer planning, or recordkeeping. A resistance-management change can affect herbicide rotation and tank-mix decisions. An ecological mitigation measure can affect field-edge planning or applications near sensitive areas. The practical effect depends on the exact wording of any final label language.
Why The Evidence Review Is Being Updated
EPA’s current work follows several earlier decisions and court actions. In 2017, EPA’s human health risk assessment concluded that glyphosate was “not likely to be carcinogenic to humans” when used according to current labeling. That finding differed from the International Agency for Research on Cancer, which classified glyphosate in 2015 as “probably carcinogenic.” The difference between those assessments has remained central to public debate, legal scrutiny, and farm-sector concern.
EPA issued an Interim Registration Review Decision in January 2020. That decision reaffirmed EPA’s position on cancer risk when glyphosate is used as labeled and proposed mitigation measures for ecological risks, including label changes related to spray drift, resistance, and aquatic hazards. On September 23, 2022, EPA withdrew all remaining portions of that interim decision after a court ruling on June 17, 2022 vacated the human health portion and found that EPA’s review triggered Endangered Species Act duties.
How The 2026 Review Changed The Timeline
Public Comment Dates And Agency Coordination
The current schedule gives stakeholders a limited but meaningful window to review EPA’s literature search approach. The original comment period for the open literature search closed on September 24, 2026. EPA extended that period on September 25, 2026 by 60 days, setting a new comment deadline of November 23, 2026. That extension matters because the literature search helps shape the evidence base for the updated human health risk assessment.
EPA and the U.S. Department of Health and Human Services also signed a Memorandum of Understanding on September 22, 2026. The stated purpose was to improve coordination on scientific topics such as surveillance of human and occupational exposure, formulation toxicity, biomonitoring, cancer risk, and related health questions. This does not by itself determine the final regulatory outcome, but it indicates that the federal review is drawing on a wider public-health framework than a narrow label-only review.
Farm groups, applicators, researchers, and community members who track pesticide standards may find it useful to follow how public participation is handled. Agheiro has covered related agency engagement issues in its article on EPA public participation in crop standards. For broader community readers in the same network, readers can check the Stuyvesant Yacht Club for examples of local organizations that engage with environmental stewardship and awareness.
What Remains Unsettled In Late 2026
As of October 14, 2026, EPA still maintained its position that glyphosate is safe for use under current labels. The agency was preparing its revised assessment for late 2026, with a public webinar likely in early 2027. Those dates matter because growers should distinguish between a review in progress and a completed regulatory decision.
The ecological side also remains active. EPA finalized a Biological Evaluation in November 2021 finding that glyphosate is “likely to adversely affect” 93% of listed species and 96% of critical habitats, primarily through effects on plants and organisms that depend on plants. Formal consultation with the U.S. Fish and Wildlife Service and National Marine Fisheries Service is ongoing. Until that process is resolved, the final shape of endangered-species-related mitigation remains uncertain.
Potential Effects On Pesticide Practices
Label Language Is The Main Farm-Level Link
The most direct way the glyphosate review process could affect pesticide practices is through label changes. EPA’s earlier mitigation discussions included spray drift, resistance, and aquatic hazards. Future label language could address application rates, buffer requirements, drift specifications, timing restrictions, or resistance-management measures. The research record does not yet support naming exact future requirements because EPA has not finalized the updated assessment.
That uncertainty creates a practical challenge. A grower planning weed control for the next crop cycle may need to make seed, herbicide, tillage, and labor decisions before federal review steps are complete. Input retailers and applicators may also need to plan training and product stewardship materials without knowing whether labels will change. The sound approach is to base applications on current labels while monitoring EPA actions before the next major use period.
Resistance And Drift Remain Central Issues
EPA’s prior mitigation language shows that resistance management and drift reduction are not side issues. Resistance concerns affect the long-term usefulness of weed-control tools. Drift concerns affect neighboring crops, sensitive habitats, water bodies, and non-target plants. If future mitigation focuses on those areas, many farms may need to adjust spray plans, review equipment settings, or refine field-edge practices.
This does not mean every farm would face the same change. A producer using custom application may see effects through applicator scheduling and service terms. A producer applying pesticides on-farm may face more direct changes in equipment setup, weather-condition thresholds, or documentation. A farm near sensitive habitat could face a different risk profile than a field surrounded by similar cropland. The regulatory text, once final, will determine the actual duties.
Public Input And Farm-Level Planning
How Comments Can Affect The Evidence Record
The open literature search document is not the final human health risk assessment. It is part of the evidence-gathering process. Public comments may address whether EPA’s search approach captures relevant studies, whether certain health topics need closer review, or whether exposure issues have been framed accurately. For agriculture, comments may also help clarify how pesticide practices occur under real field conditions, provided they are supported by data or verifiable experience.
The value of comments depends on their relevance and quality. General claims are less useful than specific information tied to exposure routes, label use, application methods, or documented field conditions. Because EPA’s review concerns federal pesticide standards, comments that connect directly to the agency’s stated scientific questions are more likely to inform the record than broad policy statements.
- Track the November 23, 2026 comment deadline if submitting information to EPA.
- Use current product labels unless and until EPA approves new label language.
- Watch for the late-2026 human health risk assessment and any early-2027 public webinar.
- Separate human-health review questions from endangered-species consultation issues, since they may move on different timelines.
Why Market Planning Needs Caution
The glyphosate review process can affect more than compliance. Herbicide availability, application windows, service capacity, and grower confidence can all influence crop-management planning. Yet the effect on input markets cannot be predicted with precision from the current record. EPA has not finalized its assessment, and no final 2026 label changes have been identified in the research provided.
For that reason, growers and advisers should avoid assuming either no change or sweeping change. The more reliable position is conditional: EPA’s review could lead to label revisions, especially in areas already identified in earlier mitigation discussions, but the exact requirements remain unknown until the agency completes the relevant steps.
Glyphosate Review Process For Crop Decisions
The glyphosate review process is best understood as a staged regulatory review rather than a single decision. EPA released a new literature search document on August 25, 2026, extended public comments to November 23, 2026, and expects to complete an updated human health risk assessment in late 2026. The agency also continues to work through endangered-species obligations and related consultations.
For crop science and pesticide practice, the key issue is how the final review may translate into label language. The areas most clearly supported by the research record are human health assessment, occupational exposure, formulation toxicity, biomonitoring, cancer risk, spray drift, resistance, aquatic hazards, and ecological mitigation. Until EPA issues final decisions, current labels remain the governing standard for use.
The glyphosate review process therefore calls for close attention rather than speculation. Producers, applicators, and advisers should watch the final assessment, read any proposed label changes carefully, and prepare for practice adjustments only when the agency’s requirements are clear.